Page last updated: 2024-10-18

histamine and Rhinitis, Allergic

histamine has been researched along with Rhinitis, Allergic in 59 studies

Rhinitis, Allergic: An inflammation of the NASAL MUCOSA triggered by ALLERGENS.

Research Excerpts

ExcerptRelevanceReference
"OVA treatment successfully induced AR model in mice with significantly increased sneezing and rubbing frequency, elevated levels of serum histamine, IL-1β, IL-10 and OVA-specific IgE."8.31Bufotalin ameliorates ovalbumin-induced allergic rhinitis by restoring the Tregs. ( Ji, Q; Li, L; Ren, S, 2023)
"Allergic rhinitis (AR), histamine-mediated upper airway inflammatory disorder, is characterized by sneezing, itching, airway hyperreactivity, etc."8.02Chitosan-centered nanosystems as sustained therapeutics for allergic rhinitis intervention: Inhibition of histamine-induced cascades. ( Chen, X; Fan, P; Liu, Y; Qin, D; Sun, M, 2021)
" The purpose of this study is to investigate the anti-allergic effect of TSL in ovalbumin (OVA)-induced allergic rhinitis (AR) guinea pigs and immunoglobulin E (IgE)-stimulated RBL-2H3 cells."7.96Tussilagone inhibits allergic responses in OVA-induced allergic rhinitis guinea pigs and IgE-stimulated RBL-2H3 cells. ( Jin, C; Liu, L; Luan, H; Wang, Y; Yang, S; Ye, K; Zhang, R, 2020)
" essential oil (AEO) on ovalbumin (OVA)-induced allergic rhinitis (AR) in rats."7.96Protective effect of Asarum sieboldii essential oil on ovalbumin induced allergic rhinitis in rat. ( Kang, H; Zhang, Z, 2020)
"To investigate the association between histamine skin reactivity and body mass index (BMI) and other clinical factors, 526 children (3-6 years old) who underwent a skin-prick test (SPT) to diagnose allergic rhinitis were enrolled."7.91Association of body mass index and season with histamine skin reactivity in Chinese children with allergic rhinitis. ( Gu, M; Yang, Y, 2019)
" Furthermore, we assessed the therapeutic effects of taurine on ovalbumin (OVA)-induced allergic rhinitis (AR) animal models."7.85The potential protective role of taurine against experimental allergic inflammation. ( Jeong, HJ; Kim, HM; Nam, SY, 2017)
" In an ovalbumin-induced model of allergic rhinitis in guinea pigs, the number of sneezing, nasal rubbing, and nasal secretion events were assessed after the nasal cavity instillation of PGD2, histamine, or a combination of PGD2and histamine."7.83Prostaglandin D2 Modulates Neuronal Excitation of the Trigeminal Ganglion to Augment Allergic Rhinitis in Guinea Pigs. ( Aoki, M; Furue, S; Goto, K; Inagaki, N; Nagira, Y; Shichijo, M; Tanaka, H; Tomita, Y, 2016)
"This study is aimed at exploring the effect of Bencycloquidium bromide (BCQB), a novel M1/M3 receptor antagonist, on mucus secretion in a murine model of allergic rhinitis (AR)."7.81Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis. ( Huang, J; Li, J; Long, R; Meng, L; Peng, L; Zhou, Y; Zhu, S, 2015)
"Pretreatment with histamine receptor-1 antagonist, azelastine prevented the early effect of nasal secretions of AR patients on epithelial integrity."6.87Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. ( Akdis, CA; Boeckxstaens, G; Boon, L; Bullens, DM; Ceuppens, JL; Farré, R; Hellings, PW; Kortekaas Krohn, I; Raap, U; Seys, SF; Steelant, B; Talavera, K; Van Gerven, L; Van Woensel, M; Wawrzyniak, P, 2018)
"Ebastine is a well-established secondgeneration oral H1-antihistamine that is administered once daily at a dose of 10-20 mg and is available both as a standard tablet and as a fast-dissolving tablet that disintegrates in the mouth."6.66Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience. ( Sastre, J, 2020)
"Allergic rhinitis is a common heterogeneous chronic upper airway disorder and is an IgE-mediated inflammation characterized by one or more nasal symptoms such as sneezing, itching, nasal discharge, rhinorrhea, post nasal drainage and nasal blockage."5.46Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release. ( Bui, TT; Chai, OH; Piao, CH; Song, CH, 2017)
"Piperine (PIP) has been reported to exhibit anti-inflammatory, anti-histaminic, and immunomodulatory activities; however, its antiallergic profile has not been studied."5.42Antiallergic effect of piperine on ovalbumin-induced allergic rhinitis in mice. ( Aswar, M; Aswar, U; Chepurwar, S; Shintre, S, 2015)
"Kaempferol (KP) is a major compound of Naju Jjok (Polygonum tinctorium Lour."5.39Evaluation of the effect of kaempferol in a murine allergic rhinitis model. ( Han, NR; Jeong, HJ; Kim, HM; Kim, MJ; Oh, HA, 2013)
"OVA treatment successfully induced AR model in mice with significantly increased sneezing and rubbing frequency, elevated levels of serum histamine, IL-1β, IL-10 and OVA-specific IgE."4.31Bufotalin ameliorates ovalbumin-induced allergic rhinitis by restoring the Tregs. ( Ji, Q; Li, L; Ren, S, 2023)
" The effect of the DPP4 inhibitor sitagliptin on the effector phase of allergic rhinitis (AR) in ovalbumin (OVA)-sensitized mice and on mast cell degranulation in vitro was assessed."4.31DPP4 Inhibitor Sitagliptin Reduces Inflammatory Responses and Mast Cell Activation in Allergic Rhinitis. ( Sun, X; Xu, Y; Zhou, J, 2023)
" We investigated AR-related behavior (sneezing and nose rubbing), as well as total immunoglobulin E (IgE), histamine, interleukin-4 (IL-4), leukotriene (LT) B4 and LTC4 levels, and gene expression of CysLT1R, HRH1, and MUC5a."4.12Effect of Temperature and Humidity on the Allegro-inflammatory Factors and Allergic Rhinitis-related Behavior. ( Liuo, Y; Mehrabi Nasab, E; Yonghua, S, 2022)
"Current medications to treat allergic rhinitis (AR) include antihistamines, corticosteroids, and anti-leukotrienes."4.12The Effects of Combined Therapeutic Protocol on Allergic Rhinitis Symptoms and Molecular Determinants. ( Athari, SS; Hassanpour, F; Mehrabi Nasab, E; Shen, Y, 2022)
"Allergic rhinitis (AR), histamine-mediated upper airway inflammatory disorder, is characterized by sneezing, itching, airway hyperreactivity, etc."4.02Chitosan-centered nanosystems as sustained therapeutics for allergic rhinitis intervention: Inhibition of histamine-induced cascades. ( Chen, X; Fan, P; Liu, Y; Qin, D; Sun, M, 2021)
" The purpose of this study is to investigate the anti-allergic effect of TSL in ovalbumin (OVA)-induced allergic rhinitis (AR) guinea pigs and immunoglobulin E (IgE)-stimulated RBL-2H3 cells."3.96Tussilagone inhibits allergic responses in OVA-induced allergic rhinitis guinea pigs and IgE-stimulated RBL-2H3 cells. ( Jin, C; Liu, L; Luan, H; Wang, Y; Yang, S; Ye, K; Zhang, R, 2020)
" essential oil (AEO) on ovalbumin (OVA)-induced allergic rhinitis (AR) in rats."3.96Protective effect of Asarum sieboldii essential oil on ovalbumin induced allergic rhinitis in rat. ( Kang, H; Zhang, Z, 2020)
"To investigate the association between histamine skin reactivity and body mass index (BMI) and other clinical factors, 526 children (3-6 years old) who underwent a skin-prick test (SPT) to diagnose allergic rhinitis were enrolled."3.91Association of body mass index and season with histamine skin reactivity in Chinese children with allergic rhinitis. ( Gu, M; Yang, Y, 2019)
"Geraniol is a monoterpene alcohol that has anti-fungal, anti-cancer and anti-nociceptive properties, but its anti-allergic rhinitis (AR) property is unclear."3.88Geraniol suppresses proinflammatory mediators in phorbol 12-myristate 13-acetate with A23187-induced HMC-1 cells. ( Huang, Y; Ni, YH; Xu, ZM; Yang, XL, 2018)
"Both histamine and leukotrienes are implicated in the pathogenesis of allergic rhinitis (AR), although the pattern and severity of the nasal response to these two potent inflammatory mediators may differ, which has not been adequately studied in patients with persistent AR."3.88Effects of leukotriene D ( Gao, Y; Guan, W; Huang, R; Xia, S; Xie, Y; Zheng, J; Zhong, N; Zhu, Z, 2018)
" Furthermore, we assessed the therapeutic effects of taurine on ovalbumin (OVA)-induced allergic rhinitis (AR) animal models."3.85The potential protective role of taurine against experimental allergic inflammation. ( Jeong, HJ; Kim, HM; Nam, SY, 2017)
"Human nasal epithelial cells from allergic rhinitis patients were cultured, and stimulated with 4 concentrations of histamine, or pretreated with a specific nuclear factor-kappa B (NF-κB) inhibitor (Bay11-7082) before histamine stimulation."3.83The role for human nasal epithelial nuclear factor kappa B activation in histamine-induced mucin 5 subtype B overproduction. ( Shao, S; Wang, S; Wang, W, 2016)
"Histamine H1 receptor (H1R) gene is upregulated in patients with allergic rhinitis (AR), and its expression level is strongly correlated with the severity of allergic symptoms."3.83A novel benzofuran, 4-methoxybenzofuran-5-carboxamide, from Tephrosia purpurea suppressed histamine H1 receptor gene expression through a protein kinase C-δ-dependent signaling pathway. ( Fukui, H; Kadota, T; Karmakar, S; Kashiwada, Y; Kitamura, Y; Mizuguchi, H; Mukherjee, PK; Nemoto, H; Shill, MC; Takeda, N, 2016)
" In an ovalbumin-induced model of allergic rhinitis in guinea pigs, the number of sneezing, nasal rubbing, and nasal secretion events were assessed after the nasal cavity instillation of PGD2, histamine, or a combination of PGD2and histamine."3.83Prostaglandin D2 Modulates Neuronal Excitation of the Trigeminal Ganglion to Augment Allergic Rhinitis in Guinea Pigs. ( Aoki, M; Furue, S; Goto, K; Inagaki, N; Nagira, Y; Shichijo, M; Tanaka, H; Tomita, Y, 2016)
" Treatment with TAPP-CZ (10 and 30 µg/kg in nostril) showed significant attenuation in OVA-induced alterations of the nasal (number of nasal rubbing and sneezing), biochemical markers (serum IgE and histamine), haematological, morphological (relative organ weight of spleen and lung) and histopathological (nasal mucosa and spleen) parameters."3.81Anti-allergic effect of intranasal administration of type-A procyanidin polyphenols based standardized extract of cinnamon bark in ovalbumin sensitized BALB/c mice. ( Aswar, UM; Kandhare, AD; Mohan, V; Thakurdesai, PA, 2015)
"This study is aimed at exploring the effect of Bencycloquidium bromide (BCQB), a novel M1/M3 receptor antagonist, on mucus secretion in a murine model of allergic rhinitis (AR)."3.81Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis. ( Huang, J; Li, J; Long, R; Meng, L; Peng, L; Zhou, Y; Zhu, S, 2015)
" The present study investigated the effects and mechanism of BS, SDS, NaCl, or mineral mixture (containing zinc, magnesium, and potassium) on ovalbumin (OVA)-induced allergic rhinitis (AR) animal model."3.78Bamboo salt reduces allergic responses by modulating the caspase-1 activation in an OVA-induced allergic rhinitis mouse model. ( Jeong, HJ; Kim, HM; Kim, KY; Nam, SY; Park, KY; Shin, TY, 2012)
"Pretreatment with histamine receptor-1 antagonist, azelastine prevented the early effect of nasal secretions of AR patients on epithelial integrity."2.87Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. ( Akdis, CA; Boeckxstaens, G; Boon, L; Bullens, DM; Ceuppens, JL; Farré, R; Hellings, PW; Kortekaas Krohn, I; Raap, U; Seys, SF; Steelant, B; Talavera, K; Van Gerven, L; Van Woensel, M; Wawrzyniak, P, 2018)
"Ebastine is a well-established secondgeneration oral H1-antihistamine that is administered once daily at a dose of 10-20 mg and is available both as a standard tablet and as a fast-dissolving tablet that disintegrates in the mouth."2.66Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience. ( Sastre, J, 2020)
"Allergic rhinitis is a common heterogeneous chronic upper airway disorder and is an IgE-mediated inflammation characterized by one or more nasal symptoms such as sneezing, itching, nasal discharge, rhinorrhea, post nasal drainage and nasal blockage."1.46Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release. ( Bui, TT; Chai, OH; Piao, CH; Song, CH, 2017)
"Histamine is an important mediator of allergic reactions, and mucus hypersecretion is a major allergic symptom."1.46Synergistic mucus secretion by histamine and IL-4 through TMEM16A in airway epithelium. ( Cho, HJ; Choi, JY; Kang, JW; Kang, MJ; Kim, CH; Lee, HJ; Lee, SN; Lee, YH; Min, HJ; Namkung, W; Oh, R; Yoon, JH, 2017)
"Piperine (PIP) has been reported to exhibit anti-inflammatory, anti-histaminic, and immunomodulatory activities; however, its antiallergic profile has not been studied."1.42Antiallergic effect of piperine on ovalbumin-induced allergic rhinitis in mice. ( Aswar, M; Aswar, U; Chepurwar, S; Shintre, S, 2015)
"Histamine is the main cause of sneezing and hypersecretion, while other mediators probably also play a role in nasal blockage."1.40Allergic rhinitis. ( Mygind, N, 2014)
"Kaempferol (KP) is a major compound of Naju Jjok (Polygonum tinctorium Lour."1.39Evaluation of the effect of kaempferol in a murine allergic rhinitis model. ( Han, NR; Jeong, HJ; Kim, HM; Kim, MJ; Oh, HA, 2013)

Research

Studies (59)

TimeframeStudies, this research(%)All Research%
pre-19903 (5.08)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's33 (55.93)24.3611
2020's23 (38.98)2.80

Authors

AuthorsStudies
Guo, J1
Xu, S2
Li, E1
Wang, D3
Xue, Y1
Yan, J1
Wang, J8
Wang, S2
Wang, L5
Hu, H2
Dong, P1
Shen, Y2
Mehrabi Nasab, E2
Hassanpour, F1
Athari, SS1
Liu, C3
Pang, C1
Chen, DS1
Yi, WQ1
Yu, N1
Chen, L3
Kuang, Y1
Hu, B2
Huang, M2
Zhao, S2
Wu, X3
Zhang, M2
Xie, Z1
Xu, H3
Chen, H1
Cai, H1
Ji, Q3
Ren, S3
Li, L7
Yonghua, S1
Liuo, Y1
Sun, X3
Xu, Y3
Zhou, J2
Jung, MA1
Song, HK1
Jo, K2
Lee, A1
Hwang, YH1
Ji, KY1
Jung, DH1
Cai, M1
Lee, JY1
Pyun, BJ1
Kim, T1
Kim, HY3
Kim, J1
Jeong, HJ7
Kim, HM7
Jin, C1
Ye, K1
Luan, H1
Liu, L2
Zhang, R2
Yang, S2
Wang, Y10
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z2
Zhou, L1
Zhao, Y3
Huang, L2
Hu, K1
Liu, H4
Wang, H4
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q5
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W3
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J6
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M2
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S3
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z2
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C2
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J9
Du, S1
Zhou, H1
Cui, J1
Wu, W2
Liu, Y9
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y3
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y4
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P2
Cao, X1
Li, CX1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y3
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z3
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Fu, P1
Atyah, M1
Ma, Q2
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X4
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C3
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X3
Huang, Y3
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ2
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J3
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y4
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J2
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y2
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Kang, H1
Sobkowiak, P1
Langwiński, W1
Nowakowska, J1
Wojsyk-Banaszak, I1
Szczepankiewicz, D1
Jenerowicz, D1
Wasilewska, E1
Bręborowicz, A1
Szczepankiewicz, A1
Van Nguyen, T1
Piao, CH2
Fan, YJ1
Shin, DU1
Kim, SY1
Song, HJ1
Song, CH2
Shin, HS1
Chai, OH2
Callebaut, I1
Steelant, B2
Backaert, W1
Peeters, R1
Sunaert, S1
Van Oudenhove, L1
Hellings, PW2
Iwasaki, N3
Terawaki, S2
Shimizu, K2
Oikawa, D2
Sakamoto, H2
Sunami, K2
Tokunaga, F2
Nam, SY4
Qin, D1
Fan, P1
Yuan, J1
Jiao, L1
Zhou, M1
Wen, X1
Kang, JW1
Lee, YH1
Kang, MJ1
Lee, HJ1
Oh, R1
Min, HJ1
Namkung, W1
Choi, JY1
Lee, SN1
Kim, CH1
Yoon, JH1
Cho, HJ1
Fu, M1
Fu, S2
Ni, S2
Zou, L1
Hong, T2
Bui, TT1
Fu, Y1
Kong, Y1
Li, M1
Ma, D1
Zhai, W1
Lin, Y1
Ren, F1
Seys, SF1
Van Gerven, L1
Van Woensel, M1
Farré, R1
Wawrzyniak, P1
Kortekaas Krohn, I1
Bullens, DM1
Talavera, K1
Raap, U1
Boon, L1
Akdis, CA1
Boeckxstaens, G1
Ceuppens, JL1
Tanticharoenwiwat, P1
Kulalert, P1
Dechatiwongse Na Ayudhya, T1
Koontongkaew, S1
Jiratchariyakul, W1
Soawakontha, R1
Booncong, P1
Poachanukoon, O1
Chang, YL1
Lin, CS1
Wang, HW1
Jian, KR1
Liu, SC1
Gu, M1
Yang, XL1
Ni, YH1
Xu, ZM1
Sastre, J1
Kusaka, E1
Sugiyama, M1
Senoo, N1
Yamamoto, A1
Sugimoto, Y1
Jones, BL1
Kearns, G1
Neville, KA1
Sherwin, CM1
Spigarelli, MM1
Leeder, JS1
Fujieda, S1
Oh, HA2
Han, NR1
Lee, BJ1
Heffner, KL1
Kiecolt-Glaser, JK1
Glaser, R1
Malarkey, WB1
Marshall, GD1
Mygind, N1
Aswar, UM1
Kandhare, AD1
Mohan, V1
Thakurdesai, PA1
Long, R1
Peng, L1
Meng, L1
Zhu, S1
Aswar, U1
Shintre, S1
Chepurwar, S1
Aswar, M1
Chen, M1
Zhou, P1
He, G1
Jie, Q1
Shao, S1
Shill, MC1
Mizuguchi, H1
Karmakar, S1
Kadota, T1
Mukherjee, PK1
Kitamura, Y1
Kashiwada, Y1
Nemoto, H1
Takeda, N1
Fukui, H1
Lluch-Bernal, M1
Dordal, MT1
Antón, E1
Campo, P1
Colás, C1
Dávila, I1
Del Cuvillo Bernal, A1
Fernández-Parra, B1
González, R1
González, ML1
Matheu, V1
Montoro, J1
Panizo, C1
Rondón, C1
Sánchez, MC1
Valero, A1
Vega, F1
Velázquez, E1
Navarro, A1
Nagira, Y1
Goto, K1
Tanaka, H1
Aoki, M1
Furue, S1
Inagaki, N1
Tomita, Y1
Shichijo, M1
Matsushita, K1
Fukuoka, A1
Nakahira, M1
Matsumoto, M1
Akasaki, S1
Yasuda, K1
Shimizu, T1
Yoshimoto, T1
Jang, JB1
Choi, Y1
Kang, IC1
Xiong, Y1
Li, GB1
Tang, Q1
Cao, M1
Huang, JB1
Xing, M1
Hu, CP1
Gong, Y1
Wang, QH1
Gao, N1
Guan, W1
Xia, S1
Huang, R1
Zhong, N1
McLAURIN, JW1
Kim, KY1
Shin, TY1
Park, KY1
HLASIVCOVA, V1
VUKOBRATOVIC, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP). Can Shedding of Epithelial Barrier Proteins be Used as Biomarker in Severe Asthma With/Out CRSwNP Manageme[NCT05365841]85 participants (Anticipated)Observational2022-05-15Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for histamine and Rhinitis, Allergic

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience.
    Journal of investigational allergology & clinical immunology, 2020, Volume: 30, Issue:3

    Topics: Administration, Oral; Butyrophenones; Histamine; Histamine H1 Antagonists; Humans; Piperidines; Rhin

2020
Nasal Hyperreactivity: Nonspecific Nasal Provocation Tests. Review by the Rhinoconjunctivitis Committee of the Spanish Society of Allergy and Clinical Immunology.
    Journal of investigational allergology & clinical immunology, 2015, Volume: 25, Issue:6

    Topics: Histamine; Humans; Methacholine Chloride; Nasal Provocation Tests; Rhinitis, Allergic

2015

Trials

4 trials available for histamine and Rhinitis, Allergic

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis.
    The Journal of allergy and clinical immunology, 2018, Volume: 141, Issue:3

    Topics: Animals; Cell Line; Cytokines; Female; Histamine; Humans; Male; Mice; Mice, Inbred BALB C; Nasal Muc

2018
Inhibitory effect of Phlai capsules on skin test responses among allergic rhinitis patients: a randomized, three-way crossover study.
    Journal of integrative medicine, 2017, Volume: 15, Issue:6

    Topics: Adult; Allergens; Animals; Anti-Allergic Agents; Cross-Over Studies; Double-Blind Method; Histamine;

2017
Variability of histamine pharmacodynamic response in children with allergic rhinitis.
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:7

    Topics: Adolescent; Anti-Allergic Agents; Area Under Curve; Child; Female; Histamine; Humans; Iontophoresis;

2013

Other Studies

53 other studies available for histamine and Rhinitis, Allergic

ArticleYear
Astragaloside IV suppresses histamine-induced inflammatory factors and mucin 5 subtype AC overproduction in nasal epithelial cells via regulation of inflammation-related genes.
    Bioengineered, 2021, Volume: 12, Issue:1

    Topics: Cells, Cultured; Cytokines; Epithelial Cells; Histamine; Histamine Antagonists; Humans; Inflammation

2021
The Protective Role of Cirsilineol against Ovalbumin-Induced Allergic Rhinitis in Mice by Suppression of Inflammation and Oxidative Stress.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2021, Volume: 40, Issue:3

    Topics: Animals; Anti-Allergic Agents; Biomarkers; Carrier Proteins; Cells, Cultured; Disease Models, Animal

2021
MiR-224 ameliorates inflammation and symptoms in mouse model of allergic rhinitis by targeting CDK9.
    Allergologia et immunopathologia, 2021, Volume: 49, Issue:6

    Topics: Animals; Cyclin-Dependent Kinase 9; Cytokines; Disease Models, Animal; Histamine; Immunoglobulin E;

2021
The Effects of Combined Therapeutic Protocol on Allergic Rhinitis Symptoms and Molecular Determinants.
    Iranian journal of allergy, asthma, and immunology, 2022, Apr-11, Volume: 21, Issue:2

    Topics: Allergens; Animals; Caspase 1; Fluticasone; Histamine; Immunoglobulin E; Leukotriene C4; Loratadine;

2022
    Experimental biology and medicine (Maywood, N.J.), 2022, Volume: 247, Issue:14

    Topics: Allergens; Animals; Cytokines; Disease Models, Animal; Histamine; Mice; Mice, Inbred BALB C; Nasal M

2022
Phosphatidylethanolamine-binding protein 1 (PEBP1) mediates the regulatory role of microRNAs (miRNAs)-205-5p in degranulation and histamine release.
    Bioengineered, 2022, Volume: 13, Issue:5

    Topics: Animals; beta-N-Acetylhexosaminidases; Cytokines; Histamine; Histamine Release; HMGB1 Protein; Immun

2022
HDAC4 depletion ameliorates IL-13-triggered inflammatory response and mucus production in nasal epithelial cells via activation of SIRT1/NF-κB signaling.
    Immunity, inflammation and disease, 2022, Volume: 10, Issue:11

    Topics: Epithelial Cells; Histamine; Histone Deacetylases; Humans; Immunoglobulin E; Interleukin-13; Mucus;

2022
Bufotalin ameliorates ovalbumin-induced allergic rhinitis by restoring the Tregs.
    Microbial pathogenesis, 2023, Volume: 174

    Topics: Animals; Cytokines; Disease Models, Animal; Histamine; Immunoglobulin E; Interleukin-10; Mice; Mice,

2023
Bufotalin ameliorates ovalbumin-induced allergic rhinitis by restoring the Tregs.
    Microbial pathogenesis, 2023, Volume: 174

    Topics: Animals; Cytokines; Disease Models, Animal; Histamine; Immunoglobulin E; Interleukin-10; Mice; Mice,

2023
Bufotalin ameliorates ovalbumin-induced allergic rhinitis by restoring the Tregs.
    Microbial pathogenesis, 2023, Volume: 174

    Topics: Animals; Cytokines; Disease Models, Animal; Histamine; Immunoglobulin E; Interleukin-10; Mice; Mice,

2023
Bufotalin ameliorates ovalbumin-induced allergic rhinitis by restoring the Tregs.
    Microbial pathogenesis, 2023, Volume: 174

    Topics: Animals; Cytokines; Disease Models, Animal; Histamine; Immunoglobulin E; Interleukin-10; Mice; Mice,

2023
Effect of Temperature and Humidity on the Allegro-inflammatory Factors and Allergic Rhinitis-related Behavior.
    Iranian journal of allergy, asthma, and immunology, 2022, Dec-24, Volume: 21, Issue:6

    Topics: Animals; Disease Models, Animal; Histamine; Humidity; Immunoglobulin E; Interleukin-4; Leukotriene C

2022
Angiotensin converting enzyme 2 activation improves allergic rhinitis and suppresses Th2 cytokine release.
    Immunity, inflammation and disease, 2023, Volume: 11, Issue:1

    Topics: Angiotensin-Converting Enzyme 2; Animals; Cytokines; Histamine; Humans; Mice; Rhinitis, Allergic; Th

2023
DPP4 Inhibitor Sitagliptin Reduces Inflammatory Responses and Mast Cell Activation in Allergic Rhinitis.
    Pharmacology, 2023, Volume: 108, Issue:2

    Topics: Animals; Cytokines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Anim

2023
Gleditsia sinensis Lam. aqueous extract attenuates nasal inflammation in allergic rhinitis by inhibiting MUC5AC production through suppression of the STAT3/STAT6 pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 161

    Topics: Animals; Cytokines; Disease Models, Animal; Gleditsia; Histamine; Humans; Immunoglobulin E; Inflamma

2023
Potential anti-inflammatory effect of Madi-Ryuk and its active ingredient tannic acid on allergic rhinitis.
    Molecular immunology, 2019, Volume: 114

    Topics: Animals; Anti-Inflammatory Agents; Caspase 1; Chemokine CXCL2; Cytokines; Disease Models, Animal; Eo

2019
Tussilagone inhibits allergic responses in OVA-induced allergic rhinitis guinea pigs and IgE-stimulated RBL-2H3 cells.
    Fitoterapia, 2020, Volume: 144

    Topics: Animals; Anti-Allergic Agents; Cell Line; Drugs, Chinese Herbal; Female; Guinea Pigs; Histamine; Imm

2020
Protective effect of Asarum sieboldii essential oil on ovalbumin induced allergic rhinitis in rat.
    Bioscience reports, 2020, 06-26, Volume: 40, Issue:6

    Topics: Animals; Anti-Allergic Agents; Asarum; Behavior, Animal; Cytokines; Disease Models, Animal; Drugs, C

2020
Neuroinflammatory Gene Expression Pattern Is Similar between Allergic Rhinitis and Atopic Dermatitis but Distinct from Atopic Asthma.
    BioMed research international, 2020, Volume: 2020

    Topics: Adolescent; Asthma; Child; Dermatitis, Atopic; Female; Histamine; Humans; Inflammation; Male; Nerve

2020
Anti-allergic rhinitis activity of α-lipoic acid via balancing Th17/Treg expression and enhancing Nrf2/HO-1 pathway signaling.
    Scientific reports, 2020, 07-27, Volume: 10, Issue:1

    Topics: Animals; Cytokines; Down-Regulation; Eosinophils; Epitopes; Goblet Cells; Heme Oxygenase-1; Histamin

2020
Brain activation after nasal histamine provocation in house dust mite allergic rhinitis patients.
    Allergy, 2021, Volume: 76, Issue:6

    Topics: Animals; Brain; Dust; Histamine; Humans; Mites; Nasal Provocation Tests; Pyroglyphidae; Rhinitis, Al

2021
Th2 cells and macrophages cooperatively induce allergic inflammation through histamine signaling.
    PloS one, 2021, Volume: 16, Issue:3

    Topics: Animals; Cells, Cultured; Histamine; Humans; Inflammation; Macrophages; Mice; Mice, Inbred BALB C; R

2021
Th2 cell-derived histamine is involved in nasal Th2 infiltration in mice.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2021, Volume: 70, Issue:5

    Topics: Allergens; Animals; Cell Movement; Histamine; Histidine Decarboxylase; Mice, Inbred BALB C; Mice, Kn

2021
Exposure of ovalbumin during pregnancy prevents the development of allergic rhinitis in offspring through the induction of mast cell autophagy.
    Cellular immunology, 2021, Volume: 365

    Topics: Allergens; Animals; Autophagy; Disease Models, Animal; Female; Histamine; Humans; Immunity, Maternal

2021
Chitosan-centered nanosystems as sustained therapeutics for allergic rhinitis intervention: Inhibition of histamine-induced cascades.
    Journal of controlled release : official journal of the Controlled Release Society, 2021, 07-10, Volume: 335

    Topics: Animals; Anti-Allergic Agents; Chitosan; Histamine; Histamine H1 Antagonists; Rats; Rhinitis, Allerg

2021
Yiqi Jiemin decoction alleviates allergic rhinitis in a guinea pig model by suppressing inflammation, restoring Th1/Th2 balance, and improving cellular metabolism.
    Aging, 2021, 07-27, Volume: 13, Issue:14

    Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Carrier Proteins; Cytokines; Disease Models, Animal;

2021
Synergistic mucus secretion by histamine and IL-4 through TMEM16A in airway epithelium.
    American journal of physiology. Lung cellular and molecular physiology, 2017, Sep-01, Volume: 313, Issue:3

    Topics: Adult; Animals; Anoctamin-1; Cells, Cultured; Chloride Channels; Epithelial Cells; Gene Expression R

2017
Anti-inflammatory effect of epigallocatechin gallate in a mouse model of ovalbumin-induced allergic rhinitis.
    International immunopharmacology, 2017, Volume: 49

    Topics: Allergens; Animals; Anti-Inflammatory Agents; Catechin; Cyclooxygenase 2; Cytokines; Disease Models,

2017
The potential protective role of taurine against experimental allergic inflammation.
    Life sciences, 2017, Sep-01, Volume: 184

    Topics: Animals; Caspase 1; Cell Line; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug;

2017
Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.
    International immunopharmacology, 2017, Volume: 52

    Topics: Allergens; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Flavonoids; Histami

2017
Mesenchymal stromal cells ameliorate acute allergic rhinitis in rats.
    Cell biochemistry and function, 2017, Volume: 35, Issue:7

    Topics: Acute Disease; Animals; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay;

2017
Chlorpheniramine attenuates histamine-mediated aquaporin 5 downregulation in human nasal epithelial cells via suppression of NF-κB activation.
    International journal of medical sciences, 2017, Volume: 14, Issue:12

    Topics: Aquaporin 5; Cells, Cultured; Chlorpheniramine; Cyclic AMP Response Element-Binding Protein; Dose-Re

2017
Association of body mass index and season with histamine skin reactivity in Chinese children with allergic rhinitis.
    Pediatrics and neonatology, 2019, Volume: 60, Issue:2

    Topics: Body Mass Index; Child; Child, Preschool; Female; Histamine; Humans; Male; Rhinitis, Allergic; Seaso

2019
Geraniol suppresses proinflammatory mediators in phorbol 12-myristate 13-acetate with A23187-induced HMC-1 cells.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Acyclic Monoterpenes; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcim

2018
Coptisine Suppresses Mast Cell Degranulation and Ovalbumin-Induced Allergic Rhinitis.
    Molecules (Basel, Switzerland), 2018, Nov-21, Volume: 23, Issue:11

    Topics: Animals; Berberine; beta-N-Acetylhexosaminidases; Cell Degranulation; Cell Line; Disease Models, Ani

2018
Genomic and non-genomic effects of glucocorticoids on allergic rhinitis model in mice.
    International immunopharmacology, 2013, Volume: 16, Issue:2

    Topics: Adenosine Triphosphate; Animals; Behavior, Animal; Cinnamates; Disease Models, Animal; Estrenes; Fem

2013
[Diagnostic and treatment of allergic rhinitis].
    Nihon Jibiinkoka Gakkai kaiho, 2013, Volume: 116, Issue:2

    Topics: Age Factors; Basophils; Histamine; Humans; Immunoglobulin E; Rhinitis, Allergic; Rhinitis, Allergic,

2013
Evaluation of the effect of kaempferol in a murine allergic rhinitis model.
    European journal of pharmacology, 2013, Oct-15, Volume: 718, Issue:1-3

    Topics: Animals; Anti-Allergic Agents; Caspase 1; Cell Line; Cytokines; Disease Models, Animal; Enzyme Activ

2013
Inhibition of IL-32 and TSLP production through the attenuation of caspase-1 activation in an animal model of allergic rhinitis by Naju Jjok (Polygonum tinctorium).
    International journal of molecular medicine, 2014, Volume: 33, Issue:1

    Topics: Administration, Oral; Animals; Caspase 1; Cell Line; Chemokine CXCL2; Cyclooxygenase 2; Cytokines; D

2014
Stress and anxiety effects on positive skin test responses in young adults with allergic rhinitis.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2014, Volume: 113, Issue:1

    Topics: Adult; Allergens; Animals; Anxiety; Biomarkers; Cross-Over Studies; Female; Histamine; Humans; Hydro

2014
Allergic rhinitis.
    Chemical immunology and allergy, 2014, Volume: 100

    Topics: Allergens; Histamine; Histamine Antagonists; Humans; Immunotherapy; Mast Cells; Nasal Polyps; Preval

2014
Anti-allergic effect of intranasal administration of type-A procyanidin polyphenols based standardized extract of cinnamon bark in ovalbumin sensitized BALB/c mice.
    Phytotherapy research : PTR, 2015, Volume: 29, Issue:3

    Topics: Administration, Intranasal; Animals; Anti-Allergic Agents; Biflavonoids; Catechin; Cinnamomum zeylan

2015
Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2015, Volume: 64, Issue:3-4

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cytokines; Disease Models, Animal; Histamine; Male

2015
Antiallergic effect of piperine on ovalbumin-induced allergic rhinitis in mice.
    Pharmaceutical biology, 2015, Volume: 53, Issue:9

    Topics: Acetates; Alkaloids; Animals; Anti-Allergic Agents; Benzodioxoles; Biomarkers; Cell Degranulation; C

2015
Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and N
    European journal of pharmacology, 2015, Nov-15, Volume: 767

    Topics: Animals; Anti-Allergic Agents; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chemokines; Disease

2015
The role for human nasal epithelial nuclear factor kappa B activation in histamine-induced mucin 5 subtype B overproduction.
    International forum of allergy & rhinology, 2016, Volume: 6, Issue:3

    Topics: Adolescent; Adult; Cells, Cultured; Female; Histamine; Humans; Male; Middle Aged; Mucin-5B; Nasal Mu

2016
A novel benzofuran, 4-methoxybenzofuran-5-carboxamide, from Tephrosia purpurea suppressed histamine H1 receptor gene expression through a protein kinase C-δ-dependent signaling pathway.
    International immunopharmacology, 2016, Volume: 30

    Topics: Animals; Anti-Allergic Agents; Benzofurans; Cytokines; Disease Models, Animal; Gene Expression Regul

2016
Prostaglandin D2 Modulates Neuronal Excitation of the Trigeminal Ganglion to Augment Allergic Rhinitis in Guinea Pigs.
    The Journal of pharmacology and experimental therapeutics, 2016, Volume: 357, Issue:2

    Topics: Action Potentials; Animals; Behavior, Animal; Electric Stimulation; Guinea Pigs; Histamine; Male; Ne

2016
Allergen endotoxins induce T-cell-dependent and non-IgE-mediated nasal hypersensitivity in mice.
    The Journal of allergy and clinical immunology, 2017, Volume: 139, Issue:1

    Topics: Allergens; Animals; Endotoxins; Histamine; Immunoglobulin E; Mice, Inbred BALB C; Mice, Knockout; My

2017
2-(4-{2-[(phenylthio)acetyl]carbonohydrazonoyl}phenoxy)acetamide as a new lead compound for management of allergic rhinitis.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016, Volume: 65, Issue:12

    Topics: Acetamides; Allergens; Animals; Anti-Allergic Agents; Caspase 1; Cell Line; Cell Survival; Cyclooxyg

2016
Xinqin exhibits the anti-allergic effect through the JAK2/STAT5 signaling pathway.
    Journal of ethnopharmacology, 2016, Dec-04, Volume: 193

    Topics: Animals; Anti-Allergic Agents; Calcimycin; Cell Degranulation; Cell Line; Disease Models, Animal; Do

2016
Effects of leukotriene D
    The clinical respiratory journal, 2018, Volume: 12, Issue:2

    Topics: Adult; Aged; Airway Resistance; Case-Control Studies; Chronic Disease; Cross-Over Studies; Female; H

2018
Desensitization by histamine (histamine azoprotein) in vertigo, periodic headaches and vasomotor (allergic) rhinitis; review of the literature and report of 102 personal cases.
    The Laryngoscope, 1946, Volume: 56

    Topics: Anaphylaxis; Desensitization, Immunologic; Headache; Histamine; Hypersensitivity; Rhinitis; Rhinitis

1946
Bamboo salt reduces allergic responses by modulating the caspase-1 activation in an OVA-induced allergic rhinitis mouse model.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2012, Volume: 50, Issue:10

    Topics: Animals; Bambusa; Caspase 1; Cell Line; Cytokines; Food Handling; Histamine; Humans; Immunoglobulin

2012
[HISTAMINOPEXY IN ALLERGIC RHINITIS].
    Casopis lekaru ceskych, 1964, Sep-04, Volume: 103

    Topics: Blood Chemical Analysis; Desensitization, Immunologic; Histamine; Humans; Immunization, Passive; Imm

1964
[The relation between allergic rhinitis and bronchial asthma and the reaction of sensitized tissue to histamine].
    Medicinski glasnik, 1954, Volume: 8, Issue:9

    Topics: Anti-Allergic Agents; Asthma; Histamine; Histamine Agents; Histamine H1 Antagonists; Humans; Rhiniti

1954